2022年12月最新中科院JCR期刊分区表数据（升级版）已经更新，欢迎查询！ 如果您对期刊系统有任何需求或者问题，欢迎反馈给我们。
 |
| 基本信息 | 登录收藏 | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名字 | Frontiers in Oncology FRONT ONCOL LetPub评分 7.4
78人评分
我要评分
声誉 7.7 影响力 6.5 速度 8.8 | |||||||||||||||||||||
| 期刊ISSN | 2234-943X | 微信扫码收藏此期刊 | ||||||||||||||||||||
| 2021-2022最新影响因子 （数据来源于搜索引擎） | 5.738 点击查看影响因子趋势图 | |||||||||||||||||||||
| 2021-2022自引率 | 8.50%点击查看自引率趋势图 | |||||||||||||||||||||
| h-index | 60 | |||||||||||||||||||||
| CiteScore |
| |||||||||||||||||||||
| 期刊简介 | Cancer Imaging and Diagnosis is dedicated to the publication of results from clinical and research studies applied to cancer diagnosis and treatment. The section aims to publish studies from the entire field of cancer imaging: results from routine use of clinical imaging in both radiology and nuclear medicine, results from clinical trials, experimental molecular imaging in humans and small animals, research on new contrast agents in CT, MRI, ultrasound, publication of new technical applications and processing algorithms to improve the standardization of quantitative imaging and image guided interventions for the diagnosis and treatment of cancer. | |||||||||||||||||||||
| 期刊官方网站 | https://www.frontiersin.org/journals/oncology | |||||||||||||||||||||
| 期刊投稿网址 | https://www.frontiersin.org/journals/oncology#author-guidelines | |||||||||||||||||||||
| 期刊语言要求 | 经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件，不仅能满足Frontiers in Oncology的语言要求，还能让Frontiers in Oncology编辑和审稿人得到更好的审稿体验，让稿件最大限度地被Frontiers in Oncology编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）帮助作者准备稿件，已助力全球15万+作者顺利发表论文。部分发表范例可查看：服务好评 论文致谢 。
提交文稿 | |||||||||||||||||||||
| 是否OA开放访问 | Yes | |||||||||||||||||||||
OA期刊相关信息 | 文章处理费：需要（ USD2950; ） 文章处理费豁免：查看说明 其他费用：没有 期刊主题关键词：cancer research、clinical oncology、cancer genetics、molecular targets、surgical oncology 相关链接：Aims & ScopeAuthor InstructionsEditorial BoardBlind peer review | |||||||||||||||||||||
| 通讯方式 | AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, SWITZERLAND, CH-1015 | |||||||||||||||||||||
| 出版商 | Frontiers Media S.A. | |||||||||||||||||||||
| 涉及的研究方向 | Biochemistry, Genetics and Molecular Biology-Cancer Research | |||||||||||||||||||||
| 出版国家或地区 | Switzerland | |||||||||||||||||||||
| 出版语言 | English | |||||||||||||||||||||
| 出版周期 | ||||||||||||||||||||||
| 出版年份 | 0 | |||||||||||||||||||||
| 年文章数 | 5691点击查看年文章数趋势图 | |||||||||||||||||||||
| Gold OA文章占比 | 99.18% | |||||||||||||||||||||
| 研究类文章占比： 文章 ÷（文章 + 综述） | 77.28% | |||||||||||||||||||||
| WOS期刊SCI分区 （ 2021-2022年最新版） | WOS分区等级：2区
| |||||||||||||||||||||
| 中科院《国际期刊预警 名单（试行）》名单 | 2023年01月发布的2023版：不在预警名单中 2021年12月发布的2021版：不在预警名单中 2021年01月发布的2020版：不在预警名单中 | |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2022年12月最新升级版） | 点击查看中科院SCI期刊分区趋势图
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月基础版） |
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2021年12月升级版） |
| |||||||||||||||||||||
| 中科院SCI期刊分区 （ 2020年12月旧的升级版） |
| |||||||||||||||||||||
| SCI期刊收录coverage | Science Citation Index Expanded (SCIE) (2020年1月，原SCI撤销合并入SCIE，统称SCIE) Scopus (CiteScore) Directory of Open Access Journals (DOAJ) | |||||||||||||||||||||
| PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=2234-943X%5BISSN%5D | |||||||||||||||||||||
| 平均审稿速度 | 网友分享经验： 14 Weeks | |||||||||||||||||||||
| 平均录用比例 | 网友分享经验： | |||||||||||||||||||||
| LetPub助力发表 | 经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍，平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务（包括SCI论文英语润色，同行资深专家修改润色，SCI论文专业翻译，SCI论文格式排版，专业学术制图等）后论文在Frontiers in Oncology顺利发表。
快看看作者怎么说吧：服务好评 论文致谢 | |||||||||||||||||||||
| 期刊常用信息链接 |
| |||||||||||||||||||||
|
|
| |
| 中国学者近期发表的论文 | |
| 1. | Development and Validation of a Prognostic Nomogram for Extremity Soft Tissue Leiomyosarcoma. Author: Xue M1, Chen G1, Dai J1, Hu J1. Journal: Front Oncol. 2019 May 1;9:346. doi: 10.3389/fonc.2019.00346. eCollection 2019. PubMed DOI |
| 2. | Modified American Joint Committee on Cancer Tumor-Node-Metastasis Staging System Based on the Node Ratio Can Further Improve the Capacity of Prognosis Assessment for Gastric Cancer Patients. Author: Yang ZL1,2, Zhu MH1, Han XJ3, Liu QW4, Long JH5, Wang CX1,2. Journal: Front Oncol. 2019 May 3;9:329. doi: 10.3389/fonc.2019.00329. eCollection 2019. PubMed DOI |
| 3. | YTHDF1 Regulates Tumorigenicity and Cancer Stem Cell-Like Activity in Human Colorectal Carcinoma. Author: Bai Y1, Yang C1, Wu R1, Huang L1, Song S2, Li W1, Yan P1, Lin C1, Li D1, Zhang Y1. Journal: Front Oncol. 2019 May 3;9:332. doi: 10.3389/fonc.2019.00332. eCollection 2019. PubMed DOI |
| 4. | Role of Exosomes in Crosstalk Between Cancer-Associated Fibroblasts and Cancer Cells. Author: Yang X1,2, Li Y1,2, Zou L1,2, Zhu Z1,2. Journal: Front Oncol. 2019 May 3;9:356. doi: 10.3389/fonc.2019.00356. eCollection 2019. PubMed DOI |
| 5. | Long-Term Outcomes of Three-Dimensional High-Dose-Rate Brachytherapy for Locally Recurrent Early T-Stage Nasopharyngeal Carcinoma. Author: Lin Y1, Ouyang Y1, Lu Z2, Liu Y1, Chen K1, Cao X1. Journal: Front Oncol. 2019 Apr 26;9:278. doi: 10.3389/fonc.2019.00278. eCollection 2019. PubMed DOI |
| 6. | Is Epstein-Barr Virus Infection Associated With Thyroid Tumorigenesis?-A Southern China Cohort Study. Author: Yu ST1, Ge JN1, Li RC2, Wei ZG1, Sun BH1, Jiang YM1, Luo JY3, Liu H1, Lei ST1. Journal: Front Oncol. 2019 Apr 26;9:312. doi: 10.3389/fonc.2019.00312. eCollection 2019. PubMed DOI |
| 7. | Epigenetic-Mediated Downregulation of Zinc Finger Protein 671 (ZNF671) Predicts Poor Prognosis in Multiple Solid Tumors. Author: Zhang J1,2, Zheng Z3, Zheng J4, Xie T1,2, Tian Y1,2, Li R1,2, Wang B1,2, Lin J1,2, Xu A1,2, Huang X1,2, Yuan Y1,2. Journal: Front Oncol. 2019 May 7;9:342. doi: 10.3389/fonc.2019.00342. eCollection 2019. PubMed DOI |
| 8. | Long Non-coding RNA CASC2 Enhances the Antitumor Activity of Cisplatin Through Suppressing the Akt Pathway by Inhibition of miR-181a in Esophageal Squamous Cell Carcinoma Cells. Author: Zhu D1, Yu Y2, Qi Y1, Wu K1, Liu D1, Yang Y1, Zhang C1, Zhao S1. Journal: Front Oncol. 2019 May 7;9:350. doi: 10.3389/fonc.2019.00350. eCollection 2019. PubMed DOI |
| 9. | Gene Expression Profiling for Diagnosis of Triple-Negative Breast Cancer: A Multicenter, Retrospective Cohort Study. Author: Wang Q1,2, Xu M1,2, Sun Y3, Chen J3, Chen C3, Qian C3, Chen Y4, Cao L5, Xu Q3,6, Du X1,2, Yang W1,2. Journal: Front Oncol. 2019 May 7;9:354. doi: 10.3389/fonc.2019.00354. eCollection 2019. PubMed DOI |
| 10. | A Megavoltage CT Image Enhancement Method for Image-Guided and Adaptive Helical TomoTherapy. Author: Liu Y1, Yue C1, Zhu J2,3, Yu H2, Cheng Y2, Yin Y2, Li B2, Dong J1. Journal: Front Oncol. 2019 May 10;9:362. doi: 10.3389/fonc.2019.00362. eCollection 2019. PubMed DOI |
|
|
  | |
|
以上SCI期刊相关数据和信息来源于网络，仅供参考。
投稿状态统计： 我要评分： | |
同领域作者分享投稿经验：共21条 （包含回复） |
我来分享 |
|
|
联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们
© 2010-2023 中国: LetPub上海分公司 网站备案号：沪ICP备10217908号-1 
沪公网安备号：31010402006960
增值电信业务经营许可证：沪B2-20211595
礼翰商务信息咨询（上海）有限公司 办公地址：上海市徐汇区漕溪北路88号圣爱大厦2103室
United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451
安全保密
